Concerns About Eye Toxicity Could Limit GSK’s Myeloma Drug Potential
US FDA Flags Safety Ahead Of Meeting
Company told more measures needed to limit damage to patients' eyes caused by antibody drug conjugate.
Company told more measures needed to limit damage to patients' eyes caused by antibody drug conjugate.